MAPT and Alzheimer disease: It is possible that TLR9 stimulation via CpG ODN can enhance the ability of microglia to inhibit this spread of tau related pathology, suggesting that induction of TLR9 signaling can be used to successfully target pathological tau in AD mouse models.